Login to Your Account

Favorable Climate for Antibiotics

ICAAC Focuses on New Drug Pipeline and Combatting MDR

By Peter Winter
BioWorld Insight Editor

Friday, September 13, 2013

A great deal has transpired in the antibiotics world since the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) last convened one year ago. As researchers and antibiotic drug developers alike meet in Denver this week for the annual meeting, the focus is squarely on new product pipeline progress and whether those innovative products nearing the marketplace will be enough to alleviate the growing concern about multidrug resistance in virulent bacteria.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription